HMS Holdings Corp., through its subsidiaries, provides cost containment solutions in the United States healthcare marketplace. It provides coordination of benefits services to government and commercial healthcare payers and sponsors to coordinate benefits for claims; and payment integrity services that ensure healthcare claims billed are accurate and appropriate, as well as offers care management and consumer engagement solutions. The company's services also enable customers to recover improper payments; prevent future improper payments; reduce fraud, waste, and abuse; improve outcomes and increase retention; and ensure regulatory compliance. It serves state Medicaid programs, commercial health plans, federal government health agencies, government and private employers, children's health insurance programs, and other healthcare payers and sponsors. The company was founded in 1974 and is headquartered in Irving, Texas.
Industry, Sector and Symbol
Stock Exchange NASDAQ
Industry Business services, not elsewhere classified
Sub-IndustryHealth Care Technology
SectorMedical
SymbolNASDAQ:HMSY
CUSIP40425J10
Phone214-453-3000
Debt
Debt-to-Equity Ratio0.39
Current Ratio4.14
Quick Ratio4.14
Price-To-Earnings
Trailing P/E Ratio44.09
Forward P/E Ratio37.31
P/E Growth3.39
Sales & Book Value
Annual Sales$521.21 million
Price / Sales3.87
Cash Flow$1.0585 per share
Price / Cash22.91
Book Value$7.21 per share
Price / Book3.36
Profitability
EPS (Most Recent Fiscal Year)$0.43
Net Income$40.05 million
Net Margins8.20%
Return on Equity8.01%
Return on Assets4.95%
Miscellaneous
Employees2,500
Outstanding Shares83,220,000
Market Cap$2,018.01
HMS (NASDAQ:HMSY) Frequently Asked Questions
What is HMS's stock symbol?
HMS trades on the NASDAQ under the ticker symbol "HMSY."
How will HMS's stock buyback program work?
HMS announced that its board has approved a share repurchase program on Saturday, November 4th 2017, which allows the company to repurchase $50,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization allows the company to purchase shares of its stock through open market purchases. Stock repurchase programs are often a sign that the company's board of directors believes its shares are undervalued.
How were HMS's earnings last quarter?
HMS Holdings Corp (NASDAQ:HMSY) released its quarterly earnings data on Friday, May, 4th. The business services provider reported $0.22 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $0.15 by $0.07. The business services provider had revenue of $141.40 million for the quarter, compared to the consensus estimate of $130.10 million. HMS had a return on equity of 8.01% and a net margin of 8.20%. The firm's revenue was up 23.5% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.14 earnings per share. View HMS's Earnings History.
When is HMS's next earnings date?
What price target have analysts set for HMSY?
9 analysts have issued 12 month target prices for HMS's stock. Their forecasts range from $17.00 to $25.00. On average, they expect HMS's stock price to reach $21.5625 in the next twelve months. This suggests that the stock has a possible downside of 11.1%. View Analyst Ratings for HMS.
What is the consensus analysts' recommendation for HMS?
9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for HMS in the last year. There are currently 3 hold ratings, 4 buy ratings and 2 strong buy ratings for the stock, resulting in a consensus recommendation of "Buy."
What are Wall Street analysts saying about HMS stock?
Here are some recent quotes from research analysts about HMS stock:
- 1. According to Zacks Investment Research, "HMS Holdings Corp. is a leading provider of cost containment solutions in the U.S. healthcare marketplace. Using innovative technology as well as extensive data services and powerful analytics, the Company delivers coordination of benefits, payment integrity, and health management and member engagement solutions to help customers recover improper payments; prevent future improper payments; reduce fraud, waste and abuse; effectively engage their members and better manage the care they receive; and ensure regulatory compliance. The Company serves commercial health plans, state government agencies, federal programs, at-risk providers, pharmacy benefit managers and employers. " (7/10/2018)
- 2. Canaccord Genuity analysts commented, "We reiterate our BUY rating and raise our PT to $24 after recently hosting investor meetings with HMS CFO Jeff Sherman. Although shares have rebounded from depressed levels, we contend there is room to move higher as the benefits from improved workflows and technology investments take hold. A scenario is coming into focus for accelerated revenue growth driven by double-digit increases in payment integrity and the new population health offering and steady margin expansion through artificial intelligence and automation. With the acquisition of competitor Cotiviti, HMS will be the only publicly traded vehicle focused on ensuring payment integrity in healthcare." (7/2/2018)
- 3. Cantor Fitzgerald analysts commented, "Solid 4Q17 results. On February 23, HMSY reported solid 4Q17 results. Revenue of $148.5 million came in ahead of FactSet consensus of $136.8 million and our estimate of $139.6 million. Revenue growth was broad-based, with double digit growth in both COB and PI. Following a timing related decline in 3Q17, COB revenue of $105.7 million grew 17.4% q/q. About $6-$8 million of COB revenue is attributable to 3Q17. PI revenue of $26.8 million grew 12.2% q/ q and benefited from the implementation of enhanced analytics. PI performance seems to be improving. Eliza revenue of $12.9 million grew 30% q/q as Eliza’s revenue tends to be back-end loaded, with 3Q and 4Q being the strongest. As year end approaches, clients seek to maximize Medicare Star ratings and HEDIS measures. Management expects Eliza to contribute meaningfully to revenue growth in 2018. Adjusted EPS of $0.49 included a $0.25 non-cash tax benefit." (2/23/2018)
Who are some of HMS's key competitors?
Some companies that are related to HMS include athenahealth (ATHN), Fair Isaac (FICO), Etsy (ETSY), Healthequity (HQY), Stamps.com (STMP), MAXIMUS (MMS), Cotiviti (COTV), TriNet Group (TNET), Conduent (CNDT), GreenSky (GSKY), Ritchie Bros. Auctioneers (RBA), Sothebys (BID), Envestnet (ENV), WNS (WNS) and Uxin (UXIN).
Who are HMS's key executives?
HMS's management team includes the folowing people:
- Mr. William C. Lucia, Chairman, Pres & CEO (Age 60)
- Mr. Jeffrey S. Sherman, Exec. VP, CFO & Treasurer (Age 52)
- Ms. Semone Wagner Neuman, Exec. VP of Operations & Information Technology (Age 54)
- Ms. Meredith W. Bjorck, Exec. VP, Gen. Counsel & Corp. Sec. (Age 42)
- Mr. Douglas M. Williams Jr., Pres of Markets & Product (Age 59)
Has HMS been receiving favorable news coverage?
Press coverage about HMSY stock has been trending positive on Monday, Accern reports. The research firm ranks the sentiment of news coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. HMS earned a media sentiment score of 0.35 on Accern's scale. They also assigned media coverage about the business services provider an impact score of 45.33 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company's share price in the near future.
Who are HMS's major shareholders?
HMS's stock is owned by many different of institutional and retail investors. Top institutional shareholders include VAN BERKOM & ASSOCIATES INC. (5.67%), American Capital Management Inc. (2.87%), Smith Graham & Co. Investment Advisors LP (0.63%), Cambiar Investors LLC (0.31%), DnB Asset Management AS (0.27%) and Scout Investments Inc. (0.19%). Company insiders that own HMS stock include Bart M Schwartz, Cynthia Nustad, Douglas M Williams, Robert Becker, Semone Neuman and William C Lucia. View Institutional Ownership Trends for HMS.
Which major investors are selling HMS stock?
HMSY stock was sold by a variety of institutional investors in the last quarter, including Cambiar Investors LLC, Smith Graham & Co. Investment Advisors LP, Fox Run Management L.L.C., Scout Investments Inc. and Municipal Employees Retirement System of Michigan. Company insiders that have sold HMS company stock in the last year include Cynthia Nustad, Douglas M Williams, Semone Neuman and William C Lucia. View Insider Buying and Selling for HMS.
Which major investors are buying HMS stock?
HMSY stock was bought by a variety of institutional investors in the last quarter, including DnB Asset Management AS, Bank of Montreal Can and American Capital Management Inc.. Company insiders that have bought HMS stock in the last two years include Bart M Schwartz and Robert Becker. View Insider Buying and Selling for HMS.
How do I buy shares of HMS?
Shares of HMSY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is HMS's stock price today?
One share of HMSY stock can currently be purchased for approximately $24.25.
How big of a company is HMS?
HMS has a market capitalization of $2.02 billion and generates $521.21 million in revenue each year. The business services provider earns $40.05 million in net income (profit) each year or $0.43 on an earnings per share basis. HMS employs 2,500 workers across the globe.
How can I contact HMS?
HMS's mailing address is 5615 High Point Drive, Irving TX, 75038. The business services provider can be reached via phone at 214-453-3000 or via email at [email protected]
MarketBeat Community Rating for HMS (NASDAQ HMSY)
MarketBeat's community ratings are surveys of what our community members think about HMS and other stocks. Vote "Outperform" if you believe HMSY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HMSY will underperform the S&P 500 over the long term. You may vote once every thirty days.
